April, 27, 2010
Indivumed Achieves ISO-9001:2008 Certification and Offers the First Certified Biobank in the World
ISO norm guarantees highest biospecimen quality for research studies.
Hamburg-based Indivumed GmbH today has achieved ISO-9001:2008 certification. The company, which offers biobank products, clinical data and research services for the development of personalized cancer therapies, is now the world’s first ISO-certified provider of human biospecimens.
“We are very pleased with the certification,” said Hartmut Juhl, CEO of Indivumed. [...]
February 02, 2010
Indivumed to Study the Integrity of Biospecimen Sampling Procedures for the U.S. National Cancer Institute
Analysis of biopsy sampling procedures a prerequisite for the development of future individualized cancer therapies
Hamburg, Germany — Hamburg-based Indivumed GmbH has been awarded a subcontract by SAIC-Frederick, Inc., under its prime contract with the U.S. National Cancer Institute (NCI) to assess the impact of sampling procedures on the integrity of cancer biospecimens and key data [...]
Events
November 16-19, 2010
EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics
EORTC-NCI-AACR International Symposium on Molecular Targets and Cancer Therapeutics
Berlin Estrel Hotel and Convention Center
Please visit us at Booth F18.
For more information, please visit the symposium website.
November 09, 2010
Biobanking Americas
The future for next generation drug discovery and personalized medicines
TIME Magazine highlighted biobanking as one of “10 Ideas Changing the World Right Now.” Biobanking is rapidly growing and thriving to change approaches to target-finding, drug development and patient treatment. It is being viewed as a key driver for next generation biomarker and drug discovery.
Select here for more information.
October 20-22, 2010
2nd Annual Cancer Targets and Therapeutics Conference
The 2010 2nd Cancer Targets & Therapeutics Conference in San Francisco, CA examines new and emerging targets and therapeutics in the area of cancer research. Speakers at the event provide case studies of emerging targets in order to address some of the issues surrounding target-based drug discovery and development.
For more information, please the conference site.
October 18–21, 2010
Global Challenges—Transatlantic Science Week 2010
The Royal Norwegian Embassy in Washington DC welcomes you to the Transatlantic Science Week 2010, to discuss key global challenges:
Carbon Capture and Storage and Clean Energy
Biobanks and Global health
From Education to Innovation
For more information please download the PDF (86 KB)
September 27, 2010
3rd Annual Biorepositories Conference 2010
Your actions today to preserve precious biological samples will significantly impact your future drug development and revenue, and drive forward biospecimen science.
Select here for more information.
June 9, 2010
ASCO Annual ’10 Meeting
First North America QIAGEN Technology Workshop for Biospecimen Collection and Biobanking in Oncology
Location: Hyatt Regency McCormick Place, Chicago, IL
Date: June 9, 2010, 9:00 am–5:00 pm
3:50–4:30PM
Prof Hartmut Juhl
President and CEO, Indivumed
Pre-, intra- and postsurgical factors determine the role of tissue for drug development and patient stratification
Abstract
Click here for more information.
June 4, 2010
ASCO Annual ’10 Meeting
Visit us at booth 20133!
“Advancing Quality through Innovation” is Theme for 2010 ASCO Annual Meeting.
Continued innovation in our research laboratories, clinics, and outpatient treatment centers, as well as at our patients’ bedsides and in our communities—all the places where we do our work—has resulted in sustained drops in cancer death rates during the past eight years. As oncology professionals, [...]
April 17, 2010
AACR 101st Annual Meeting 2010
Conquering Cancer Through Discovery Research
The AACR 101st Annual Meeting 2010 will be held April 17–21, 2010 in Washington, DC. The 2010 Annual Meeting, with the theme of “Conquering Cancer Through Discovery Research,” will highlight the best cancer science and medicine from institutions all over the world. The complex nature of cancer requires an interdisciplinary approach [...]
March 10, 2010
Tucson Symposium 2010
Driving Pathology and Oncology Forward to Improve Patient Care
This year’s Tucson Symposium will focus on:
– Discoveries in leading edge research topics: genomics and stem cells
– Advances in diagnosis and treatment: focus on Hemateopathology
– New technology for tissue diagnostics
Select here for more information.
March 01, 2010
12th Bergmeyer Conference
Novel Biomarkers: From Discovery to Clinical Application
Experts will discuss the status of biomarker development, the prospect for novel biomarkers and challenges for biomarker discovery and development. The special focus is preanalytical aspects such as procedures for tissue collection and processing, which can significantly affect discovery programs. Prof. Juhl, CEO of Indivumed, will provide an overview [...]
February 17, 2010
Fighting a Smarter War Against Cancer
Personalized Medicine & The Cure For Cancer
The newly founded Otto J. Ruesch Center for the Cure of Gastrointestinal (GI) Cancers of Georgetown University, will arrange a symposium for medical professionals, researchers and patient advocates.
The title of the lecture from Prof. Juhl, CEO of Indivumed, is: “Tissue as diagnostic tool.”
Please visit the Ruesch Center for Gastrointestinal [...]
